Naïve T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy

Journal of Virology

Volumn 80, Issue 20, 2006, Pages 10229-10236

  Delobel, Pierre ^a,b   Nugeyre, Marie Thérèse ^a   Cazabat, Michelle ^b   Sandres Sauné, Karine ^b   Pasquier, Christophe ^b   Cuzin, Lise ^b   Marchou, Bruno ^b   Massip, Patrice ^b   Cheynier, Rémi ^a   Barré Sinoussi, Françoise ^a   Izopet, Jacques ^b   Israël, Nicole ^a  

^a INSTITUT PASTEUR   (France)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 160;

APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; TREATMENT DURATION; VIRUS REPLICATION; VIRUS STRAIN; ADULT; CD4 LYMPHOCYTE COUNT; DNA SEQUENCE; DRUG EFFECT; FLOW CYTOMETRY; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; MIDDLE AGED; MOLECULAR GENETICS; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION; THYMUS; VIROLOGY; VIRUS LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; HIV ENVELOPE PROTEIN GP160; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; MIDDLE AGED; MOLECULAR SEQUENCE DATA; RECEPTORS, CXCR4; RESEARCH SUPPORT, NON-U.S. GOV'T; SEQUENCE ANALYSIS, DNA; T-LYMPHOCYTE SUBSETS; THYMUS GLAND; VIRAL LOAD;

EID: 33749491636     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00965-06     Document Type: Article

References (45)

1. Almeida, A. R., J. A. Borghans, and A. A. Freitas. 2001. T cell homeostasis: thymus regeneration and peripheral T cell restoration in mice with a reduced fraction of competent precursors. J. Exp. Med. 194:591-599.
2. Anthony, K. B., C. Yoder, J. A. Metcalf, R. DerSimonian, J. M. Orenstein, R. A. Stevens, J. Falloon, M. A. Polis, H. C. Lane, and I. Sereti. 2003. Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover. J. Acquir. Immune Defic. Syndr. 33:125-133.
3. + T cell homeostasis and function in advanced HIV disease. Science 277:112-116.
4. + T lymphocytes. J. Immunol. 173:7150-7160.
5. + cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads. J. Infect. Dis. 191:1670-1679.
6. Bleul, C. C., L. Wu, J. A. Hoxie, T. A. Springer, and C. R. Mackay. 1997. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA 94:1925-1930.
7. Brooks, D. G., S. G. Kitchen, C. M. Kitchen, D. D. Scripture-Adams, and J. A. Zack. 2001. Generation of HIV latency during thymopoiesis. Nat. Med. 7:459-464.
8. David, D., H. Keller, L. Nait-Ighil, M. P. Treilhou, M. Joussemet, B. Dupont, B. Gachot, J. Maral, and J. Theze. 2002. Involvement of Bcl-2 and IL-2R in HIV-positive patients whose CD4 cell counts fail to increase rapidly with highly active antiretroviral therapy. AIDS 16:1093-1101.
9. Delobel, P., K. Sandres-Saune, M. Cazabat, C. Pasquier, B. Marchou, P. Massip, and J. Izopet. 2005. R5 to X4 switch of the predominant HIV-1 population in cellular reservoirs during effective highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 38:382-392.
10. Dion, M. L., J. F. Poulin, R. Bordi, M. Sylvestre, R. Corsini, N. Kettaf, A. Dalloul, M. R. Boulassel, P. Debre, J. P. Routy, Z. Grossman, R. P. Sekaly, and R. Cheynier. 2004. HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation. Immunity 21:757-768.
11. Douek, D. C., M. R. Betts, B. J. Hill, S. J. Little, R. Lempicki, J. A. Metcalf, J. Casazza, C. Yoder, J. W. Adelsberger, R. A. Stevens, M. W. Baseler, P. Keiser, D. D. Richman, R. T. Davey, and R. A. Koup. 2001. Evidence for increased T cell turnover and decreased thymic output in HIV infection. J. Immunol. 167:6663-6668.
12. Douek, D. C., R. D. McFarland, P. H. Keiser, E. A. Gage, J. M. Massey, B. F. Haynes, M. A. Polis, A. T. Haase, M. B. Feinberg, J. L. Sullivan, B. D. Jamieson, J. A. Zack, L. J. Picker, and R. A. Koup. 1998. Changes in thymic function with age and during the treatment of HIV infection. Nature 396:690-695.
13. Fouchier, R. A., M. Groenink, N. A. Kootstra, M. Tersmette, H. G. Huisman, F. Miedema, and H. Schuitemaker. 1992. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J. Virol. 66:3183-3187.
14. Furtado, M. R., D. S. Callaway, J. P. Phair, K. J. Kunstman, J. L. Stanton, C. A. Macken, A. S. Perelson, and S. M. Wolinsky. 1999. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy. N. Engl. J. Med. 340:1614-1622.
15. Grabar, S., V. Le Moing, C. Goujard, C. Leport, M. D. Kazatchkine, D. Costagliola, and L. Weiss. 2000. Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy. Ann. Intern. Med. 133:401-410.
16. Grossman, Z., B. Min, M. Meier-Schellersheim, and W. E. Paul. 2004. Concomitant regulation of T-cell activation and homeostasis. Nat. Rev. Immunol. 4:387-395.
17. + thymocytes through sustained induction of Bcl-2. Blood 98:2166-2174.
18. Harris, J. M., M. D. Hazenberg, J. F. Poulin, D. Higuera-Alhino, D. Schmidt, M. Gotway, and J. M. McCune. 2005. Multiparameter evaluation of human thymic function: interpretations and caveats. Clin. Immunol. 115:138-146.
19. Hazenberg, M. D., S. A. Otto, J. W. Cohen Stuart, M. C. Verschuren, J. C. Borleffs, C. A. Boucher, R. A. Coutinho, J. M. Lange, T. F. Rinke de Wit, A. Tsegaye, J. J. van Dongen, D. Hamann, R. J. de Boer, and F. Miedema. 2000. Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection. Nat. Med. 6:1036-1042.
20. Hazenberg, M. D., S. A. Otto, D. Hamann, M. T. Roos, H. Schuitemaker, R. J. de Boer, and F. Miedema. 2003. Depletion of naive CD4 T cells by CXCR4-using HIV-1 variants occurs mainly through increased T-cell death and activation. AIDS 17:1419-1424.
21. + T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J. Infect. Dis. 187:1534-1543.
22. Karlsson, I., J. C. Grivel, S. S. Chen, A. Karlsson, J. Albert, E. M. Fenyo, and L. B. Margolis. 2005. Differential pathogenesis of primary CCR5-using human immunodeficiency virus type 1 isolates in ex vivo human lymphoid tissue. J. Virol. 79:11151-11160.
23. Kaufmann, G. R., L. Perrin, G. Pantaleo, M. Opravil, H. Furrer, A. Telenti, B. Hirschel, B. Ledergerber, P. Vernazza, E. Bernasconi, M. Rickenbach, M. Egger, and M. Battegay. 2003. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. Arch. Intern. Med. 163:2187-2195.
24. Kimmig, S., G. K. Przybylski, C. A. Schmidt, K. Laurisch, B. Mowes, A. Radbruch, and A. Thiel. 2002. Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J. Exp. Med. 195:789-794.
25. + HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J. Exp. Med. 200:331-343.
26. Kornfeld, C., M. J. Ploquin, I. Pandrea, A. Faye, R. Onanga, C. Apetrei, V. Poaty-Mavoungou, P. Rouquet, J. Estaquier, L. Mortara, J. F. Desoutter, C. Butor, R. Le Grand, P. Roques, F. Simon, F. Barre-Sinoussi, O. M. Diop, and M. C. Muller-Trutwin. 2005. Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J. Clin. Investig. 115:1082-1091.
27. + T lymphocytes by intermittent IL-2 therapy in HIV-infected patients. J. Clin. Investig. 115:2139-2148.
28. Kwa, D., J. Vingerhoed, B. Boeser, and H. Schuitemaker. 2003. Increased in vitro cytopathicity of CC chemokine receptor 5-restricted human immunodeficiency virus type 1 primary isolates correlates with a progressive clinical course of infection. J. Infect. Dis. 187:1397-1403.
29. Lafeuillade, A., L. Chollet, G. Hittinger, N. Profizi, O. Costes, and C. Poggi. 1998. Residual human immunodeficiency virus type 1 RNA in lymphoid tissue of patients with sustained plasma RNA of <200 copies/ml. J. Infect. Dis. 177:235-238.
30. Lecoeur, H., E. Ledru, M. C. Prevost, and M. L. Gougeon. 1997. Strategies for phenotyping apoptotic peripheral human lymphocytes comparing ISNT, annexin-V and 7-AAD cytofluorometric staining methods. J. Immunol. Methods 209:111-123.
31. Lewin, S. R., R. M. Ribeiro, G. R. Kaufmann, D. Smith, J. Zaunders, M. Law, A. Solomon, P. U. Cameron, D. Cooper, and A. S. Perelson. 2002. Dynamics of T cells and TCR excision circles differ after treatment of acute and chronic HIV infection. J. Immunol. 169:4657-4666.
32. + T cells. Nature 434:1148-1152.
33. + T cells in multiple tissues during acute SIV infection. Nature 434:1093-1097.
34. McCune, J. M., R. Loftus, D. K. Schmidt, P. Carroll, D. Webster, L. B. Swor-Yim, I. R. Francis, B. H. Gross, and R. M. Grant. 1998. High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. J. Clin. Investig. 101:2301-2308.
35. + T cells are massively infected and eliminated by X4-tropic simian-human immunodeficiency viruses in macaques. Proc. Natl. Acad. Sci. USA 102:8000-8005.
36. Nobile, M., R. Correa, J. A. Borghans, C. D'Agostino, P. Schneider, R. J. De Boer, and G. Pantaleo. 2004. De novo T-cell generation in patients at different ages and stages of HIV-1 disease. Blood 104:470-477.
37. Popovic, M., K. Tenner-Racz, C. Pelser, H. J. Stellbrink, J. van Lunzen, G. Lewis, V. S. Kalyanaraman, R. C. Gallo, and P. Racz. 2005. Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA 102:14807-14812.
38. Ramratnam, B., J. E. Mittler, L. Zhang, D. Boden, A. Hurley, F. Fang, C. A. Macken, A. S. Perelson, M. Markowitz, and D. D. Ho. 2000. The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy. Nat. Med. 6:82-85.
39. Repits, J., M. Oberg, J. Esbjornsson, P. Medstrand, A. Karlsson, J. Albert, E. M. Fenyo, and M. Jansson. 2005. Selection of human immunodeficiency virus type 1 R5 variants with augmented replicative capacity and reduced sensitivity to entry inhibitors during severe immunodeficiency. J. Gen. Virol. 86:2859-2869.
40. Reyes, R. A., D. R. Canfield, U. Esser, L. A. Adamson, C. R. Brown, C. Cheng-Mayer, M. B. Gardner, J. M. Harouse, and P. A. Luciw. 2004. Induction of simian AIDS in infant rhesus macaques infected with CCR5- or CXCR4-utilizing simian-human immunodeficiency viruses is associated with distinct lesions of the thymus. J. Virol. 78:2121-2130.
41. + mature thymocytes correlates with their capacity to favor human immunodeficiency X4 virus replication. J. Virol. 77:5784-5793.
42. + human thymocytes with high CXCR4-induced chemotaxis. Proc. Natl. Acad. Sci. USA 102:12867-12872.
43. Taylor, J. R., Jr., K. C. Kimbrell, R. Scoggins, M. Delaney, L. Wu, and D. Camerini. 2001. Expression and function of chemokine receptors on human thymocytes: implications for infection by human immunodeficiency virus type 1. J. Virol. 75:8752-8760.
44. Teixeira, L., H. Valdez, J. M. McCune, R. A. Koup, A. D. Badley, M. K. Hellerstein, L. A. Napolitano, D. C. Douek, G. Mbisa, S. Deeks, J. M. Harris, J. D. Barbour, B. H. Gross, I. R. Francis, R. Halvorsen, R. Asaad, and M. M. Lederman. 2001. Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function. AIDS 15:1749-1756.
45. Trouplin, V., F. Salvatori, F. Cappello, V. Obry, A. Brelot, N. Heveker, M. Alizon, G. Scarlatti, F. Clavel, and F. Mammano. 2001. Determination of coreceptor usage of human immunodeficiency virus type 1 from patient plasma samples by using a recombinant phenotypic assay. J. Virol. 75:251-259.